We are live on
!
Find out more
WVP
Worth Venture Partners Portfolio holdings
AUM
$31.6M
1-Year Est. Return
28.5%
This Fund
S&P 500
This Quarter
Est. Return
+12.98%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$206M
AUM Growth
+$80M
(+63%)
Cap. Flow
-$1.07M
Cap. Flow
% of AUM
-0.52%
Top 10 Holdings %
Top 10 Hldgs %
40.32%
Holding
148
New
41
Increased
22
Reduced
20
Closed
37
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVVE
Nuvve Holding Corp
NVVE
|
+$4.72M |
| 2 |
TLND
Talend S.A. American Depositary Shares
TLND
|
+$3.42M |
| 3 |
DZSI
DZS Inc. Common Stock
DZSI
|
+$2.83M |
| 4 |
THER
THERATECHNOLOGIES INC COM
THER
|
+$2.73M |
| 5 |
Puma Biotechnology
PBYI
|
+$2.53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Blue Bird Corp
BLBD
|
+$3.79M |
| 2 |
CLDR
Cloudera, Inc.
CLDR
|
+$3.52M |
| 3 |
F5
FFIV
|
+$3.34M |
| 4 |
BFX
BowFlex Inc.
BFX
|
+$3M |
| 5 |
COHR
Coherent Inc
COHR
|
+$3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.62% |
| 2 | Healthcare | 12.27% |
| 3 | Consumer Discretionary | 3.1% |
| 4 | Financials | 2.19% |
| 5 | Industrials | 1.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALNA
26
DELISTED
Allena Pharmaceuticals
ALNA
| $1.36M | 0.66% |
980,200
+470,000
| +92% | +$783K |
|
27
Carvana
CVNA
$68.6B
| $1.36M | 0.66% |
+25,915
| New | +$1.43M |
|
|
PRTK
28
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $1.35M | 0.65% |
191,093
| – | – |
|
29
OneMain Financial
OMF
$7.2B
| $1.31M | 0.64% |
+24,431
| New | +$1.26M |
|
|
HOME
30
DELISTED
At Home Group Inc.
HOME
| $1.26M | 0.61% |
+43,899
| New | +$1.1M |
|
|
INFI
31
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $1.25M | 0.61% |
+387,141
| New | +$1.29M |
|
|
ALIM
32
DELISTED
Alimera Sciences
ALIM
| $1.23M | 0.59% |
127,333
| – | – |
|
|
LUNA
33
DELISTED
Luna Innovations Incorporated
LUNA
| $1.2M | 0.58% |
113,604
+892
| +0.8% | +$9.97K |
|
34
Raymond James Financial
RJF
$33.8B
| $1.19M | 0.58% |
+14,532
| New | +$1.08M |
|
35
Myomo
MYO
$39M
| $1.17M | 0.57% |
91,664
-18,200
| -17% | -$220K |
|
|
YTEN
36
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
| $1.12M | 0.54% |
+3,721
| New | +$1.26M |
|
37
Booking.com
BKNG
$149B
| $1.07M | 0.52% |
11,525
+2,300
| +25% | +$204K |
|
38
Processa Pharmaceuticals
PCSA
$5.95M
| $942K | 0.46% |
+182
| New | +$848K |
|
39
Microchip Technology
MCHP
$40.3B
| $881K | 0.43% |
+11,358
| New | +$847K |
|
|
ENV
40
DELISTED
ENVESTNET, INC.
ENV
| $847K | 0.41% |
+11,728
| New | +$912K |
|
|
ZUO
41
DELISTED
Zuora, Inc.
ZUO
| $841K | 0.41% |
56,845
+9,163
| +19% | +$137K |
|
42
Annovis Bio
ANVS
$74.4M
| $836K | 0.41% |
29,968
-89,570
| -75% | -$1.92M |
|
|
DSPG
43
DELISTED
DSP Group Inc
DSPG
| $810K | 0.39% |
56,831
+12,131
| +27% | +$194K |
|
44
Pixelworks
PXLW
$38.2M
| $809K | 0.39% |
20,358
-15,088
| -43% | -$629K |
|
|
MDNA
45
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
| $807K | 0.39% |
+197,900
| New | +$806K |
|
46
Franklin Covey
FC
$242M
| $803K | 0.39% |
+28,379
| New | +$742K |
|
47
TechTarget
TTGT
$325M
| $792K | 0.38% |
11,400
-4,230
| -27% | -$329K |
|
|
FARO
48
DELISTED
Faro Technologies
FARO
| $790K | 0.38% |
9,127
-400
| -4% | -$33.1K |
|
49
Etsy
ETSY
$7.75B
| $774K | 0.38% |
3,836
-212
| -5% | -$44.4K |
|
50
Bank of America
BAC
$435B
| $744K | 0.36% |
+19,229
| New | +$664K |
|
Similar funds
VL
SP
OGC
PE
RL
AIIC
LGM
SCA
Worth Venture Partners's Q1 2021 Portfolio in Review
As of Q1 2021, Worth Venture Partners held 148 positions worth $206M, up 63% from $126M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Worth Venture Partners's Q1 2021 filing shows 41 new, 22 increased, 20 reduced and 37 closed positions. Its largest new stake was Nuvve Holding Corp: 1 share worth $1.93M. The largest sale was Blue Bird Corp, an estimated $3.79M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Worth Venture Partners's largest Q1 2021 buy was Nuvve Holding Corp: 1 share worth $1.93M.
- Worth Venture Partners added most to THERATECHNOLOGIES INC COM in Q1 2021, an estimated $2.73M increase.
- Worth Venture Partners's biggest Q1 2021 reduction was Avaya Holdings Corp. Common Stock, cutting an estimated $2.03M.
- Worth Venture Partners fully exited Blue Bird Corp in Q1 2021, selling an estimated $3.79M.
- Worth Venture Partners's ten largest holdings make up 40% of its $206M portfolio in Q1 2021.
- Worth Venture Partners opened 41 new positions and closed 37 in Q1 2021.
- Worth Venture Partners's portfolio value rose 63% quarter-over-quarter to $206M.
Based on Worth Venture Partners's 13F filing for Q1 2021, filed 17 May 2021.